Download | < Back |
19 Apr 2017 | |
Clarification on news item appeared on CNBC TV18 dated 19th April, 2017 captioned US FDA Issues 5-6 'Largely Procedural' Observations To Aurobindo Pharma's Unit-III'. | |
View all announcements for AUROBINDO PHARMA LTD. | Source: BSE India |